Biogen Inc (NASDAQ:BIIB)

262.15
Delayed Data
As of 4:00pm ET
 +2.85 / +1.10%
Today’s Change
244.28
Today|||52-Week Range
370.57
-17.71%
Year-to-Date
Biogen (BIIB) Q1 Earnings Beat, Sales Miss, Shares Down
12:18pm / Zacks.com - Paid Partner Content
What's in Store for Biogen (BIIB) This Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
Biogen (BIIB) Q1 Earnings Beat, Sales Miss
8:02am / Zacks.com - Paid Partner Content
Broadleaf Partners, LLC Buys NVIDIA Corp, Sherwin-Williams Co, Schwab International E...
Apr 20 / GuruFocus News - Paid Partner Content
Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN
Apr 23 / Zacks.com - Paid Partner Content
Mylan Fujifilm Kyowa Team Up to Market Humira Biosimilar
Apr 12 / Zacks.com - Paid Partner Content
Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus
Apr 23 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: NextEra, Danaher, Biogen, Facebook and Apple
Apr 12 / Zacks.com - Paid Partner Content
Novartis (NVS) Reports Encouraging Data on MS Candidate
Apr 20 / Zacks.com - Paid Partner Content
Top Research Reports for NextEra, Danaher & Biogen
Apr 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close259.30
Today’s open253.71
Day’s range249.17 - 266.73
Volume3,619,822
Average volume (3 months)1,599,041
Market cap$60.5B
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-29.56%
Earnings growth (this year)+13.87%
Earnings growth (next 5 years)+5.57%
Revenue growth (last year)+7.81%
P/E ratio22.0
Price/Sales6.17
Price/Book4.80

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-7.35-2.99%
GILDGilead Sciences-1.29-1.74%
----
----
Data as of 4:00pm ET, 04/24/2018

Financials

Last reporting dateApril 24, 2018
EPS forecast (this quarter)$5.92
Annual revenue (last year)$11.0B
Annual profit (last year)$2.5B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts